|
|
| Product Name: | CA 19-9 | | Synonyms: | Human Carbohydrate Antigen 19-9 ELISA Kit;GASTROINTESTINAL TUMOR ANTIGEN;CA 19-9;CA19-9 (GASTROINTESTINAL CANCER);CA 19-9, HUMAN;CANCER ANTIGEN 19-9, HUMAN;CANCER ANTIGEN (CA 19-9);CANCER ASSOCIATED, CA 19-9 | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![CA 19-9 Structure]() |
| | CA 19-9 Chemical Properties |
| storage temp. | −20°C | | form | buffered aqueous solution |
| Hazard Codes | Xn,B | | Risk Statements | 20/21/22-22-21/22 | | Safety Statements | 36/37 | | WGK Germany | - | | Storage Class | 8A - Combustible corrosive hazardous materials | | Hazard Classifications | Met. Corr. 1 |
| | CA 19-9 Usage And Synthesis |
| Biological Activity | Cancer antigen 19-9 or carbohydrate antigen 19-9 is synthesized by pancreatic and biliary ductular cells, as well as by salivary, colonic, gastric, endometrial epithelia. It is also found in seminal fluid. In tissues, CA 19-9 exists as an epitope present on a glycolipid, whereas in serum, it is associated with mucin. CA 19-9 is a marker for pancreatic, gastric and hepatobiliary malignancies and is found in elevated levels. | | Description | The Human CA19-9 Cancer Antigen is having a molecular mass of approximately 210kDa and was purified from human carcinoma cell line. | | Source | Human carcinoma cell line | | Background | CA19-9 Cancer Antigen , aka CA19-9, is a cell surface glycoprotein complex most commonly associated with pancreatic ductal adenocarcinoma.
The immunohistologic distribution of CA19-9 in tissues is consistent with the quantitative determination of higher CA19-9 concentrations in cancer than in normal or inflamed tissues. CA19-9 Cancer Antigen is a tumour marker raised in blood of patients with carcinoma of the gastro-intestinal tract.
A declining Cancer Antigen CA19-9 value may be indicative of a favorable prognosis and good response to treatment. |
| | CA 19-9 Preparation Products And Raw materials |
|